Indira Ghandhi Institute of Medical Science Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT00680940
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

IGIDS | Indira Gandhi Institute of Dental Science | Regional Cancer center, Indira Gandhi Medical College | Regional Cancer Centre, Indira Ghandhi Institute of Medical Science

Active Ingredients

Drugs in Phase 2 Trials (3)

cisplatin (platinol) (1 trial)

immuvac (1 trial)

paclitaxel (taxol) (1 trial)

Drugs in Other Trials (1)

sodium fluoride (18F) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4